44th Europlx Pharma Partnering Event Expects Another Record Attendance

Dielheim/Heidelberg, (PresseBox) - .
- Last two events overbooked
- Most international pharma partnering event
- Next euroPLX event filling rapidly

Medical E-Mail News(TM) / July 30 2010 -- 15 Years after the first euroPLX Meeting, which was held on June 20 1995 in Frankfurt Germany, euroPLX has become the pharma industry's most international partnering event, with delegates from an average of 36 countries attending each event.

The first two 2010 events were overbooked. For the organizers, RauCon business development, this is a clear sign that the pragmatic euroPLX concept is favored in difficult economic times, owing to its unique resultstocost ratio.

The next euroPLX event will be euroPLX 44 Barcelona, to be held on Nov 8-9 2010, in the Hilton Diagonal Mar, Barcelona, Spain. This pharma and biopharma partnering event is already halfway booked. An early registration bonus of EUR 200 will be granted for registrations received by Sept 8 2010.

RauCon business development

euroPLX® (short for European Pharma License Exchange) is a brainchild and Europe registered trademark of RauCon. As a specialist consultancy for providing and organizing business development opportunities, RauCon caters to international pharma and biopharma business development and licensing executives, with organizational tools for the optimization of the business development process, advice and career support.

Having organized partnering events in Europe, North America, and Australia since 1987, RauCon has pioneered the Pharma License Exchange concept in 1995, a novel business development platform for the pharmaceutical industry. Since then each single euroPLX Meeting was meticulously planned and prepared by Dr. Norbert Rau and Mrs. Anke Rau who have an uptodate perspective on the industry since more than two decades.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.